Inhibikase Therapeutics (IKT) EBITDA (2021 - 2026)
Inhibikase Therapeutics' EBITDA came in at -$21.05 million for Q2 2026, compared with -$10.81 million a year earlier.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) EBITDA (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Inhibikase Therapeutics reported EBITDA of -$65.41 million; for FY2025, it came in at -$51.91 million.
- Going back by year, EBITDA was -$28.56 million in FY2024, -$19.91 million in FY2023, -$18.12 million in FY2022 and -$14.77 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBITDA in data going back to Q4 2021.
- Business Quant data shows IKT's EBITDA at -$17.84 million (Q1 2026), -$13.78 million (Q4 2025) and -$12.74 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Inhibikase Therapeutics | 288.92 Mn | -296.56 Mn | - | -21.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.05 Mn |
| Mar 31, 2026 | -17.84 Mn |
| Dec 31, 2025 | -13.78 Mn |
| Sep 30, 2025 | -12.74 Mn |
| Jun 30, 2025 | -10.81 Mn |
| Mar 31, 2025 | -14.59 Mn |
| Dec 31, 2024 | -12.92 Mn |
| Sep 30, 2024 | -5.82 Mn |
| Jun 30, 2024 | -5.04 Mn |
| Mar 31, 2024 | -4.78 Mn |
| Dec 31, 2023 | -4.40 Mn |
| Sep 30, 2023 | -4.76 Mn |
| Jun 30, 2023 | -6.04 Mn |
| Mar 31, 2023 | -4.71 Mn |
| Dec 31, 2022 | -4.33 Mn |
| Sep 30, 2022 | -4.51 Mn |
| Jun 30, 2022 | -4.64 Mn |
| Mar 31, 2022 | -4.64 Mn |
| Dec 31, 2021 | -5.04 Mn |
API Access
Inhibikase Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();